You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.


BCRF News x


NEW YORK, NY – December 11, 2019 – The Breast Cancer Research Foundation (BCRF) announced $5 million in funding provided by Eli Lilly and Company to conduct investigator-initiated studies of the CDK4 & 6 inhibitor, Verzenio® (abemaciclib).

Raise money for lifesaving research this holiday season and throughout the new year.
BCRF attended the fifth annual Conquer Cancer Scientific and Career Development Retreat designed to empower early career researchers.
Group Photo
Learn how you can become a Team BCRF runner in this year’s 13.1-mile race
Pink Press Fall 2019
The inspiration of a BCRF metastasis researcher, recaps from signature events, ASCO 2019 science updates and more
A BCRF researcher since 2003, Dr. Winer will be recognized for his pioneering achievements made in breast cancer research.
BCRF is the largest private funder of metastatic breast cancer research in the world.
podcast art
Mapping and understanding brain metastasis
The network’s campaign features a new PSA and content centered around their commitment to BCRF.
grant announcement 2019
BCRF announces research priorities for 2019-2020, including $27 million for MBC research.